|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ANKRD42-RHOD (FusionGDB2 ID:4837) |
Fusion Gene Summary for ANKRD42-RHOD |
Fusion gene summary |
Fusion gene information | Fusion gene name: ANKRD42-RHOD | Fusion gene ID: 4837 | Hgene | Tgene | Gene symbol | ANKRD42 | RHOD | Gene ID | 338699 | 29984 |
Gene name | ankyrin repeat domain 42 | ras homolog family member D | |
Synonyms | PPP1R79|SARP | ARHD|RHOHP1|RHOM|Rho | |
Cytomap | 11q14.1 | 11q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | ankyrin repeat domain-containing protein 42protein phosphatase 1, regulatory subunit 79several ankyrin repeat protein | rho-related GTP-binding protein RhoDRho-related protein HP1ras homolog Dras homolog gene family, member Aras homolog gene family, member D | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | GRK7 | |
Ensembl transtripts involved in fusion gene | ENST00000528190, ENST00000393389, ENST00000528722, ENST00000260047, ENST00000526731, ENST00000531895, ENST00000393392, ENST00000533342, | ENST00000308831, ENST00000533360, ENST00000532559, | |
Fusion gene scores | * DoF score | 6 X 6 X 3=108 | 10 X 6 X 6=360 |
# samples | 6 | 15 | |
** MAII score | log2(6/108*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/360*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ANKRD42 [Title/Abstract] AND RHOD [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ANKRD42(82959129)-RHOD(66837896), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across ANKRD42 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across RHOD (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-AN-A0FZ-01A | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
ChimerDB4 | BRCA | TCGA-AN-A0FZ-01A | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
ChimerDB4 | BRCA | TCGA-AN-A0FZ-01A | ANKRD42 | chr11 | 82959129 | - | RHOD | chr11 | 66837896 | + |
Top |
Fusion Gene ORF analysis for ANKRD42-RHOD |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000528190 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
3UTR-3UTR | ENST00000528190 | ENST00000533360 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
3UTR-3UTR | ENST00000528190 | ENST00000532559 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3CDS | ENST00000393389 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3UTR | ENST00000393389 | ENST00000533360 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3UTR | ENST00000393389 | ENST00000532559 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3CDS | ENST00000528722 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3UTR | ENST00000528722 | ENST00000533360 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3UTR | ENST00000528722 | ENST00000532559 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
In-frame | ENST00000260047 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
5CDS-3UTR | ENST00000260047 | ENST00000533360 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
5CDS-3UTR | ENST00000260047 | ENST00000532559 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3CDS | ENST00000526731 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3UTR | ENST00000526731 | ENST00000533360 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
intron-3UTR | ENST00000526731 | ENST00000532559 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
In-frame | ENST00000531895 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
5CDS-3UTR | ENST00000531895 | ENST00000533360 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
5CDS-3UTR | ENST00000531895 | ENST00000532559 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
3UTR-3CDS | ENST00000393392 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
3UTR-3UTR | ENST00000393392 | ENST00000533360 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
3UTR-3UTR | ENST00000393392 | ENST00000532559 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
In-frame | ENST00000533342 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
5CDS-3UTR | ENST00000533342 | ENST00000533360 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
5CDS-3UTR | ENST00000533342 | ENST00000532559 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000260047 | ANKRD42 | chr11 | 82959129 | + | ENST00000308831 | RHOD | chr11 | 66837896 | + | 2973 | 2259 | 150 | 2561 | 803 |
ENST00000531895 | ANKRD42 | chr11 | 82959129 | + | ENST00000308831 | RHOD | chr11 | 66837896 | + | 2454 | 1740 | 234 | 2042 | 602 |
ENST00000533342 | ANKRD42 | chr11 | 82959129 | + | ENST00000308831 | RHOD | chr11 | 66837896 | + | 2518 | 1804 | 26 | 1441 | 471 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000260047 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + | 0.007045128 | 0.9929549 |
ENST00000531895 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + | 0.00715628 | 0.9928437 |
ENST00000533342 | ENST00000308831 | ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837896 | + | 0.001789317 | 0.99821067 |
Top |
Fusion Genomic Features for ANKRD42-RHOD |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837895 | + | 1.98E-08 | 1 |
ANKRD42 | chr11 | 82959129 | + | RHOD | chr11 | 66837895 | + | 1.98E-08 | 1 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ANKRD42-RHOD |
Go to FGviewer for the breakpoints of chr11:82959129-chr11:66837896 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | RHOD |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | 553 |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | RHOD | chr11:82959129 | chr11:66837896 | ENST00000308831 | 2 | 5 | 129_132 | 110.0 | 211.0 | Nucleotide binding | GTP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 130_159 | 0 | 199.0 | Repeat | Note=ANK 4 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 163_192 | 0 | 199.0 | Repeat | Note=ANK 5 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 200_232 | 0 | 199.0 | Repeat | Note=ANK 6 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 235_265 | 0 | 199.0 | Repeat | Note=ANK 7 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 25_60 | 0 | 199.0 | Repeat | Note=ANK 1 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 269_298 | 0 | 199.0 | Repeat | Note=ANK 8 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 302_332 | 0 | 199.0 | Repeat | Note=ANK 9 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 64_93 | 0 | 199.0 | Repeat | Note=ANK 2 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393389 | + | 1 | 6 | 97_126 | 0 | 199.0 | Repeat | Note=ANK 3 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 130_159 | 0 | 390.0 | Repeat | Note=ANK 4 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 163_192 | 0 | 390.0 | Repeat | Note=ANK 5 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 200_232 | 0 | 390.0 | Repeat | Note=ANK 6 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 235_265 | 0 | 390.0 | Repeat | Note=ANK 7 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 25_60 | 0 | 390.0 | Repeat | Note=ANK 1 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 269_298 | 0 | 390.0 | Repeat | Note=ANK 8 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 302_332 | 0 | 390.0 | Repeat | Note=ANK 9 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 64_93 | 0 | 390.0 | Repeat | Note=ANK 2 |
Hgene | ANKRD42 | chr11:82959129 | chr11:66837896 | ENST00000393392 | + | 1 | 10 | 97_126 | 0 | 390.0 | Repeat | Note=ANK 3 |
Tgene | RHOD | chr11:82959129 | chr11:66837896 | ENST00000308831 | 2 | 5 | 46_54 | 110.0 | 211.0 | Motif | Effector region | |
Tgene | RHOD | chr11:82959129 | chr11:66837896 | ENST00000308831 | 2 | 5 | 24_31 | 110.0 | 211.0 | Nucleotide binding | GTP | |
Tgene | RHOD | chr11:82959129 | chr11:66837896 | ENST00000308831 | 2 | 5 | 71_75 | 110.0 | 211.0 | Nucleotide binding | GTP |
Top |
Fusion Gene Sequence for ANKRD42-RHOD |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000260047_ENST00000308831_TCGA-AN-A0FZ-01A_ANKRD42_chr11_82959129_+_RHOD_chr11_66837896_length(transcript)=2973nt_BP=2259nt TGGAGGATAAACGGTCTACACGGCCATTCCGGCGCCGAGTCTAGGGAAAGAGTTAGCGACGACGGGGAAAGAAAATGTGAAGAGAGCGAC CGCCGCTCCAGGGTCGCTGCAGGAAGCCTAAGTGCAGACGCCGGCTTCTCCCGCAGTGACTTGAGAAGGGTCAGTGAAAACCTCGGCCAC TGCCGCAGCGTCTCTAGGGAGAGAGTTAGGGGAGATAGTGGCCACAGTCACAGCTGCTCTTGGGAGAGAGTTAGGGGAGACAGCACCTTC TGCAGCAGCGACGTGAATTTTAGTGAAGTTGGAGGCCACCAAACTACCGACTCCAGGGGAACAGCCAGAGAAGACCGAGGCCTCCGCCTC AGTGGTCCTTGGGAGGGAGTCAGTGACATTCGGGACCCGCGAACTAGTGACTTCGGGGATAGAGTCAGTGACGATCGCAGTCGCCGCTTC AGTGGCTCCTGGGAGGGAGGGAGTGTCGAAGGCGGCCACAGCGTTGGTAGTTCTTGGGAGGAAGTAAGTGGAGACCGCGGCTACGCAGCC AGCGACTCCTCTGGTGTGAGCGGCAGTGAAGACGCCAGCTACCGCTTCAGTGGCTTTTGGGAGAGAGAAAGTGAAGACGAAGGTTTCCGC TGCAGCTTCTGGGAGAGAGCAAGAGAGGACCTTGGGCCCCGTCCTAGTGACGACGGAGAAGAGGGCCGCTGCCGCTGCAGTGGCTCGTGG GTGAGAGCAAGTGAAGACCGCCGCAGCATCAGGGGCCTGGACTCAACTCCTCCCCAGAGTCGGAGGTGTTGCGCCATGCCCGGGGTGGCC AATTCAGGCCCCTCCACTTCCTCTAGGGAGACTGCAAACCCCTGTTCCAGGAAGAAGGTGCATTTTGGCAGCATACATGATGCAGTACGA GCTGGAGATGTAAAGCAGCTTTCAGAAATAGTGGTACGTGGAGCCAGCATTAATGAACTTGATGTTCTCCATAAGTTTACCCCTTTACAT TGGGCAGCACATTCTGGAAGTTTGGAGTGTCTTCATTGGCTGCTCTGGCATGGAGCTGATATCACACACGTAACAACGAGAGGTTGGACA GCATCTCACATAGCTGCAATCAGGGGTCAGGATGCTTGTGTACAGGCTCTTATAATGAATGGAGCAAATCTGACAGCCCAGGATGACCGG GGATGCACTCCTTTACATCTTGCTGCAACTCATGGACATTCTTTCACTTTACAAATAATGCTCCGAAGTGGAGATCCCAGTGTGACTGAT AAGAGAGAATGGAGACCTGTGCATTATGCAGCTTTTCATGGGCGGCTTGGCTGCTTGCAACTTCTTGTTAAATGGGGTTGTAGCATAGAA GATGTGGACTACAATGGAAACCTTCCAGTTCACTTAGCAGCCATGGAAGGCCACCTTCACTGTTTCAAATTCCTAGTCAGTAGAATGAGC AGTGCGACGCAAGTTTTAAAAGCTTTCAATGATAATGGAGAAAATGTACTGGATTTGGCCCAGAGGTTCTTCAAGCAGAACATTTTACAG TTTATCCAGGGGGCTGAGTATGAAGGAAAAGACCTAGAGGATCAGGAAACTTTAGCATTTCCAGGTCATGTGGCTGCCTTTAAGGGTGAT TTGGGGATGCTTAAGAAATTAGTGGAAGATGGAGTAATCAATATTAATGAGCGTGCTGATAATGGATCAACTCCTATGCATAAAGCTGCT GGACAAGGCCACATAGAGTGTTTGCAGTGGTTAATTAAAATGGGAGCAGACAGTAATATTACCAACAAAGCAGGGGAGAGACCCAGTGAT GTGGCAAAGAGGTTTGCCCATTTGGCAGCAGTGAAGCTGTTAGAGGAGCTACAGAAATATGATATAGATGACGAAAATGAAATTGATGAA AATGATGTGAAATATTTTATAAGACATGGTGTTGAGGGAAGCACTGATGCCAAGGATGATTTATGTCTGAGTGACTTGGATAAAACAGAT GCCAGAATGAGAGCTTACAAGAAAATTGTAGAATTGAGACACCTCCTGGAAATTGCCGAGAGCAACTATAAACACTTGGGAGGCATAACA GAAGAAGATTTAAAGCAGAAGAAAGAACAGCTTGAGTCTGAAAAGACCATCAAAGAACTGCAGGGCCAGCTGGAGTATGAACGACTACGT AGAGAAAAATTAGAATGTCAGCTTGATGAATATCGAGCAGAAGTTGATCAACTCAGGGAAACACTGGAAAAAATTCAAGTCCCAAACTTT GTGGCTATGTGGTACCCAGAAGTGAATCATTTCTGCAAGAAGGTACCCATCATCGTCGTGGGCTGCAAGACTGACCTGTGCAAGGACAAA TCACTGGTGAACAAGCTCCGAAGAAACGGATTGGAGCCTGTGACCTACCACAGGGGCCAGGAGATGGCGAGGTCCGTGGGCGCGGTGGCC TACCTCGAGTGCTCGGCTCGGCTCCATGACAACGTCCACGCCGTCTTCCAGGAGGCCGCCGAGGTGGCCCTCAGCAGCCGCGGTCGCAAC TTCTGGCGGCGGATTACCCAGGGCTTTTGCGTGGTGACCTGAGCGGCTCGGGGCGTCCCAGCGACGCGGGAAGGGGCAGGGCGCTGACCT GCTGCTGAGCTGGCTGGGCTGGACCCGGTCCCTAGGCTGTGACCGCCGAACTCCACTGCAACAGACGGGCGCCACCAAAGCCAGGCCCTG AGGCCTGGGAGTCCTGGACTGAGAAAGGGGGTTCCTGGGCCCACCTGCTCTGTGTAGGGCTCGTCCTGCGGTGCCCGAGAATCACTCGCT AACCCCTATGCCCGGTCCCGGACCGACATCCTGGAGCCGCCTGTGCAGCCTGATGCCCCCTCGTGGCTGCTCCCAGGGCTGCACCTGCCA GGACCTAATGTTCTTAGGTCCCTCTGGCCAGAACCCACACCCGGCCCCTTCCCACCTGTCATACTGGTAACTGTAACAAGAAAAACGACA >In-frame_ENST00000260047_ENST00000308831_TCGA-AN-A0FZ-01A_ANKRD42_chr11_82959129_+_RHOD_chr11_66837896_length(amino acids)=803AA_start in transcript=150_stop in transcript=2561 MRRVSENLGHCRSVSRERVRGDSGHSHSCSWERVRGDSTFCSSDVNFSEVGGHQTTDSRGTAREDRGLRLSGPWEGVSDIRDPRTSDFGD RVSDDRSRRFSGSWEGGSVEGGHSVGSSWEEVSGDRGYAASDSSGVSGSEDASYRFSGFWERESEDEGFRCSFWERAREDLGPRPSDDGE EGRCRCSGSWVRASEDRRSIRGLDSTPPQSRRCCAMPGVANSGPSTSSRETANPCSRKKVHFGSIHDAVRAGDVKQLSEIVVRGASINEL DVLHKFTPLHWAAHSGSLECLHWLLWHGADITHVTTRGWTASHIAAIRGQDACVQALIMNGANLTAQDDRGCTPLHLAATHGHSFTLQIM LRSGDPSVTDKREWRPVHYAAFHGRLGCLQLLVKWGCSIEDVDYNGNLPVHLAAMEGHLHCFKFLVSRMSSATQVLKAFNDNGENVLDLA QRFFKQNILQFIQGAEYEGKDLEDQETLAFPGHVAAFKGDLGMLKKLVEDGVININERADNGSTPMHKAAGQGHIECLQWLIKMGADSNI TNKAGERPSDVAKRFAHLAAVKLLEELQKYDIDDENEIDENDVKYFIRHGVEGSTDAKDDLCLSDLDKTDARMRAYKKIVELRHLLEIAE SNYKHLGGITEEDLKQKKEQLESEKTIKELQGQLEYERLRREKLECQLDEYRAEVDQLRETLEKIQVPNFVAMWYPEVNHFCKKVPIIVV -------------------------------------------------------------- >In-frame_ENST00000531895_ENST00000308831_TCGA-AN-A0FZ-01A_ANKRD42_chr11_82959129_+_RHOD_chr11_66837896_length(transcript)=2454nt_BP=1740nt GACCGCGGCTACGCAGCCAGCGACTCCTCTGGTGTGAGCGGCAGTGAAGACGCCAGCTACCGCTTCAGTGGCTTTTGGGAGAGAGAAAGT GAAGACGAAGGTTTCCGCTGCAGCTTCTGGGAGAGAGCAAGAGAGGACCTTGGGCCCCGTCCTAGTGACGACGGAGAAGAGGGCCGCTGC CGCTGCAGTGGCTCGTGGGTGAGAGCAAGTGAAGACCGCCGCAGCATCAGGGGCCTGGACTCAACTCCTCCCCAGAGTCGGAGGTGTTGC GCCATGCCCGGGGTGGCCAATTCAGGCCCCTCCACTTCCTCTAGGGAGACTGCAAACCCCTGTTCCAGGAAGAAGGTGCATTTTGGCAGC ATACATGATGCAGTACGAGCTGGAGATGTAAAGCAGCTTTCAGAAATAGTGGTACGTGGAGCCAGCATTAATGAACTTGATGTTCTCCAT AAGTTTACCCCTTTACATTGGGCAGCACATTCTGGAAGTTTGGAGTGTCTTCATTGGCTGCTCTGGCATGGAGCTGATATCACACACGTA ACAACGAGAGGTTGGACAGCATCTCACATAGCTGCAATCAGGGGTCAGGATGCTTGTGTACAGGCTCTTATAATGAATGGAGCAAATCTG ACAGCCCAGGATGACCGGGGATGCACTCCTTTACATCTTGCTGCAACTCATGGACATTCTTTCACTTTACAAATAATGCTCCGAAGTGGA GTGGATCCCAGTGTGACTGATAAGAGAGAATGGAGACCTGTGCATTATGCAGCTTTTCATGGGCGGCTTGGCTGCTTGCAACTTCTTGTT AAATGGGGTTGTAGCATAGAAGATGTGGACTACAATGGAAACCTTCCAGTTCACTTAGCAGCCATGGAAGGCCACCTTCACTGTTTCAAA TTCCTAGTCAGTAGAATGAGCAGTGCGACGCAAGTTTTAAAAGCTTTCAATGATAATGGAGAAAATGTACTGGATTTGGCCCAGAGGTTC TTCAAGCAGAACATTTTACAGTTTATCCAGGGGGCTGAGTATGAAGGAAAAGACCTAGAGGATCAGGAAACTTTAGCATTTCCAGGTCAT GTGGCTGCCTTTAAGGGTGATTTGGGGATGCTTAAGAAATTAGTGGAAGATGGAGTAATCAATATTAATGAGCGTGCTGATAATGGATCA ACTCCTATGCATAAAGCTGCTGGACAAGGCCACATAGAGTGTTTGCAGTGGTTAATTAAAATGGGAGCAGACAGTAATATTACCAACAAA GCAGGGGAGAGACCCAGTGATGTGGCAAAGAGGTTTGCCCATTTGGCAGCAGTGAAGCTGTTAGAGGAGCTACAGAAATATGATATAGAT GACGAAAATGAAATTGATGAAAATGATGTGAAATATTTTATAAGACATGGTGTTGAGGGAAGCACTGATGCCAAGGATGATTTATGTCTG AGTGACTTGGATAAAACAGATGCCAGAATGAGAGCTTACAAGAAAATTGTAGAATTGAGACACCTCCTGGAAATTGCCGAGAGCAACTAT AAACACTTGGGAGGCATAACAGAAGAAGATTTAAAGCAGAAGAAAGAACAGCTTGAGTCTGAAAAGACCATCAAAGAACTGCAGGGCCAG CTGGAGTATGAACGACTACGTAGAGAAAAATTAGAATGTCAGCTTGATGAATATCGAGCAGAAGTTGATCAACTCAGGGAAACACTGGAA AAAATTCAAGTCCCAAACTTTGTGGCTATGTGGTACCCAGAAGTGAATCATTTCTGCAAGAAGGTACCCATCATCGTCGTGGGCTGCAAG ACTGACCTGTGCAAGGACAAATCACTGGTGAACAAGCTCCGAAGAAACGGATTGGAGCCTGTGACCTACCACAGGGGCCAGGAGATGGCG AGGTCCGTGGGCGCGGTGGCCTACCTCGAGTGCTCGGCTCGGCTCCATGACAACGTCCACGCCGTCTTCCAGGAGGCCGCCGAGGTGGCC CTCAGCAGCCGCGGTCGCAACTTCTGGCGGCGGATTACCCAGGGCTTTTGCGTGGTGACCTGAGCGGCTCGGGGCGTCCCAGCGACGCGG GAAGGGGCAGGGCGCTGACCTGCTGCTGAGCTGGCTGGGCTGGACCCGGTCCCTAGGCTGTGACCGCCGAACTCCACTGCAACAGACGGG CGCCACCAAAGCCAGGCCCTGAGGCCTGGGAGTCCTGGACTGAGAAAGGGGGTTCCTGGGCCCACCTGCTCTGTGTAGGGCTCGTCCTGC GGTGCCCGAGAATCACTCGCTAACCCCTATGCCCGGTCCCGGACCGACATCCTGGAGCCGCCTGTGCAGCCTGATGCCCCCTCGTGGCTG CTCCCAGGGCTGCACCTGCCAGGACCTAATGTTCTTAGGTCCCTCTGGCCAGAACCCACACCCGGCCCCTTCCCACCTGTCATACTGGTA >In-frame_ENST00000531895_ENST00000308831_TCGA-AN-A0FZ-01A_ANKRD42_chr11_82959129_+_RHOD_chr11_66837896_length(amino acids)=602AA_start in transcript=234_stop in transcript=2042 MDSTPPQSRRCCAMPGVANSGPSTSSRETANPCSRKKVHFGSIHDAVRAGDVKQLSEIVVRGASINELDVLHKFTPLHWAAHSGSLECLH WLLWHGADITHVTTRGWTASHIAAIRGQDACVQALIMNGANLTAQDDRGCTPLHLAATHGHSFTLQIMLRSGVDPSVTDKREWRPVHYAA FHGRLGCLQLLVKWGCSIEDVDYNGNLPVHLAAMEGHLHCFKFLVSRMSSATQVLKAFNDNGENVLDLAQRFFKQNILQFIQGAEYEGKD LEDQETLAFPGHVAAFKGDLGMLKKLVEDGVININERADNGSTPMHKAAGQGHIECLQWLIKMGADSNITNKAGERPSDVAKRFAHLAAV KLLEELQKYDIDDENEIDENDVKYFIRHGVEGSTDAKDDLCLSDLDKTDARMRAYKKIVELRHLLEIAESNYKHLGGITEEDLKQKKEQL ESEKTIKELQGQLEYERLRREKLECQLDEYRAEVDQLRETLEKIQVPNFVAMWYPEVNHFCKKVPIIVVGCKTDLCKDKSLVNKLRRNGL -------------------------------------------------------------- >In-frame_ENST00000533342_ENST00000308831_TCGA-AN-A0FZ-01A_ANKRD42_chr11_82959129_+_RHOD_chr11_66837896_length(transcript)=2518nt_BP=1804nt CTCCCCAGAGTCGGAGGTGTTGCGCCATGCCCGGGGTGGCCAATTCAGGCCCCTCCACTTCCTCTAGGGAGACTGCAAACCCCTGTTCCA GGAAGAAGGTGCATTTTGGCAGCATACATGATGCAGTACGAGCTGGAGATGTAAAGCAGCTTTCAGAAATAGTGGTACGTGGAGCCAGCA TTAATGAACTTGATGTTCTCCATAAGTTTACCCCTTTACATTGGGCAGCACATTCTGGAAGTTTGGAGTGTCTTCATTGGCTGCTCTGGC ATGGAGCTGATATCACACACGTAACAACGAGAGGTTGGACAGCATCTCACATAGCTGCAATCAGGGGTCAGGATGCTTGTGTACAGGCTC TTATAATGAATGGAGCAAATCTGACAGCCCAGGATGACCGGGGATGCACTCCTTTACATCTTGCTGCAACTCATGGACATTCTTTCACTT TACAAATAATGCTCCGAAGTGGAGTGGATCCCAGTGTGACTGATAAGAGAGAATGGAGACCTGTGCATTATGCAGCTTTTCATGGGCGGC TTGGCTGCTTGCAACTTCTTGTTAAATGGGGTTGTAGCATAGAAGATGTGGACTACAATGGAAACCTTCCAGTTCACTTAGCAGCCATGG AAGGCCACCTTCACTGTTTCAAATTCCTAGTCAGTAGAATGAGCAGTGCGACGCAAGTTTTAAAAGCTTTCAATGATAATGGAGAAAATG TACTGGATTTGGCCCAGAGGTTCTTCAAGCAGAACATTTTACAGTTTATCCAGGGGGCTGAGTATGAAGGAAAAGACCTAGAGGATCAGG AAACTTTAGCATTTCCAGGTCATGTGGCTGCCTTTAAGGGTGATTTGGGGATGCTTAAGAAATTAGTGGAAGATGGAGTAATCAATATTA ATGAGCGTGCTGATAATGGATCAACTCCTATGCATAAAGCTGCTGGACAAGGCCACATAGAGTGTTTGCAGTGGTTAATTAAAATGGGAG CAGACAGTAATATTACCAACAAAGCAGGGGAGAGACCCAGTGATGTGGCAAAGAGGTTTGCCCATTTGGCAGCAGTGAAGCTGTTAGAGG AGCTACAGAAATATGATATAGATGACGAAAATGAAATTGATGAAAATGATGTGAAATATTTTATAAGACATGGTGTTGAGGGAAGCACTG ATGCCAAGGATGATTTATGTCTGAGTGACTTGGATAAAACAGATGCCAGAATGAGAGCTTACAAGAAAATTGTAGAATTGAGACACCTCC TGGAAATTGCCGAGAGCAACTATAAACACTTGGGAGGCATAACAGAAGAAGATTTAAAGCAGAAGAAAGAACAGCTTGAGTCTGAAAAGT TGGTGTCCTTTTTAATACATTTATTTTTCTCAAGAAGTATATACAAGAGTGGCCAAGAGTACAAGCTTTGGGCTGGGGCTCTTTGGACTT GAATCCTGGCTATAGTCTTTTTTGATTTGGGCTACTCATTTAACCTTTTTGTGCCTCAACTATAAACTGGAGATGATAACTTATACTTTC TAGAGCTGATGACAGGATTAAAGGAATACACACACACACACACACACACACACACACACACACACACTCTATATGTAACTATAACTTTCT AGATACATACACACATCTGTCTATCTATCTTCAAACAGCAGCCTAGTTCATAAGTATTATTGTTAACATTGTACCATAGAAGGAGAAAAT GTTTTCATAAGTAATCAATCAGAATTCTAAGACAGCTAGAGGATATGTATATTTTAATATTCTAAATAACCAAAATAAAGTGCTTTGAAT GGAATGGTACCCAGAAGTGAATCATTTCTGCAAGAAGGTACCCATCATCGTCGTGGGCTGCAAGACTGACCTGTGCAAGGACAAATCACT GGTGAACAAGCTCCGAAGAAACGGATTGGAGCCTGTGACCTACCACAGGGGCCAGGAGATGGCGAGGTCCGTGGGCGCGGTGGCCTACCT CGAGTGCTCGGCTCGGCTCCATGACAACGTCCACGCCGTCTTCCAGGAGGCCGCCGAGGTGGCCCTCAGCAGCCGCGGTCGCAACTTCTG GCGGCGGATTACCCAGGGCTTTTGCGTGGTGACCTGAGCGGCTCGGGGCGTCCCAGCGACGCGGGAAGGGGCAGGGCGCTGACCTGCTGC TGAGCTGGCTGGGCTGGACCCGGTCCCTAGGCTGTGACCGCCGAACTCCACTGCAACAGACGGGCGCCACCAAAGCCAGGCCCTGAGGCC TGGGAGTCCTGGACTGAGAAAGGGGGTTCCTGGGCCCACCTGCTCTGTGTAGGGCTCGTCCTGCGGTGCCCGAGAATCACTCGCTAACCC CTATGCCCGGTCCCGGACCGACATCCTGGAGCCGCCTGTGCAGCCTGATGCCCCCTCGTGGCTGCTCCCAGGGCTGCACCTGCCAGGACC >In-frame_ENST00000533342_ENST00000308831_TCGA-AN-A0FZ-01A_ANKRD42_chr11_82959129_+_RHOD_chr11_66837896_length(amino acids)=471AA_start in transcript=26_stop in transcript=1441 MPGVANSGPSTSSRETANPCSRKKVHFGSIHDAVRAGDVKQLSEIVVRGASINELDVLHKFTPLHWAAHSGSLECLHWLLWHGADITHVT TRGWTASHIAAIRGQDACVQALIMNGANLTAQDDRGCTPLHLAATHGHSFTLQIMLRSGVDPSVTDKREWRPVHYAAFHGRLGCLQLLVK WGCSIEDVDYNGNLPVHLAAMEGHLHCFKFLVSRMSSATQVLKAFNDNGENVLDLAQRFFKQNILQFIQGAEYEGKDLEDQETLAFPGHV AAFKGDLGMLKKLVEDGVININERADNGSTPMHKAAGQGHIECLQWLIKMGADSNITNKAGERPSDVAKRFAHLAAVKLLEELQKYDIDD ENEIDENDVKYFIRHGVEGSTDAKDDLCLSDLDKTDARMRAYKKIVELRHLLEIAESNYKHLGGITEEDLKQKKEQLESEKLVSFLIHLF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ANKRD42-RHOD |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ANKRD42-RHOD |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ANKRD42-RHOD |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |